6/9/2020PHIIC: Urban Chinese Hospital Drug Market Declined 25% in Q1

6/8/2020Alphamab and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cance...

6/8/2020CASI Pharma Submits IND To Conduct Phase 1 Study For Anti-38 mAb in UK

6/8/2020Chinese CMDO MabPlex Nets CNY 500M in Series B Round

6/8/2020CDE Issues New Regulation for and First Batch List of Its External Exp...

6/8/2020NMPA Solicits Comments on the Rules for Medical Representative Filing ...

6/7/2020Sanofi Launches Orphan Drug Fabrazyme in China

6/5/2020China Issues the Notice for Highlights of Correction of Irregularities...

6/5/2020CDE Solicits Comments on the Technical Guidelines for Clinical Design ...

6/5/2020CDE Solicits Comments on the Technical Guidelines for Clinical Communi...

6/5/2020Recent Executive Moves

6/4/2020Beijing Plans to Criminalize Criticisms of Traditional Chinese Medicin...

6/3/2020Sanofi Genzyme's Aldurazyme Approved in China through Priority Review

6/3/2020Harbour BioMed Announces IND Approval for HBM9161 by NMPA

6/3/2020Dealing with the Chinese Economy after COVID-19

6/2/2020CDE Solicits Feedbacks on Draft Technical Guidance for Package Integri...

6/2/2020CDE Solicits Feedbacks on Draft Technical Guidance for Plastic Compone...

6/1/2020Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting ...

6/1/2020Chinese Antitrust Authority Imposes Maximum Fine In Rare Abuse Of Coll...

6/1/2020Junshi Biosciences, Merck Partner on SCCHN Combo Therapy

6/1/2020EMA Accepts First Application for Chinese-made Biosimilar HLX02

5/29/2020NMPA Issues List of Reference Formulations for Generic Drug Equivalenc...

5/29/2020Recent Executive Moves

5/29/2020Financial-related Company News in Brief

5/28/2020Challenges Posed to Chinese Biotechs in Post-Pandemic Era

5/28/2020SMEI Bluebook 2020: Chinese Retail Pharmacy Market (Offline and Online...

5/28/2020SMEI Bluebook 2020: Urban and County Level Public Hospital Drug Market...

5/28/2020CDE Publishes Draft Clinical Research Design Guidelines for Liraglutid...

5/26/2020Sino Biopharma and Akeso Files NDA for Penpulimab in China

5/26/2020Considerations on the Protection of Remdesivir under Trademark Law

Page:115/357 Total number of articles:10684: [First][<<] [113] [114] [115] [116] [117] [>>] [End]